Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Elisabetta, Meneghini"'
Autor:
Milena, Sant, Elisabetta, Meneghini, Joana, Bastos, Paolo Giorgi, Rossi, Marcela, Guevara, Kaire, Innos, Alexander, Katalinic, Leire Gil, Majuelo, Rafael, Marcos-Gragera, Florence, Molinié, Elisabetta, Rapiti, Ana, Vizcaino, Vesna, Zadnik, Pamela, Minicozzi, E, Fournier
Publikováno v:
Breast Cancer Research and Treatment. 183:439-450
Endocrine therapy (ET) is the mainstream adjuvant treatment for ER-positive breast cancer (BC). We analysed 9293 ER-positive BC patients diagnosed in nine European countries in 2009–2013 to investigate how comorbidities at diagnosis, age, stage and
Autor:
Roberto, Lillini, Andrea, Tittarelli, Martina, Bertoldi, David, Ritchie, Alexander, Katalinic, Ron, Pritzkuleit, Guy, Launoy, Ludivine, Launay, Elodie, Guillaume, Tina, Žagar, Carlo, Modonesi, Elisabetta, Meneghini, Camilla, Amati, Francesca, Di Salvo, Paolo, Contiero, Alessandro, Borgini, Paolo, Baili
Publikováno v:
Reviews of environmental contamination and toxicology. 256
Health risks at population level may be investigated with different types of environmental studies depending on access to data and funds. Options include ecological studies, case-control studies with individual interviews and human sample analysis, r
Autor:
Milena Sant, Elisabetta Meneghini, Alba Fiorentino, Riccardo Valdagni, Maria De Santis, Angelo Vitullo, Carlotta Giandini, Massimiliano Gennaro, Emanuele Pignoli, Laura Lozza, E. La Rocca, F. Bonfantini, S. Di Cosimo
Publikováno v:
Journal of cancer research and clinical oncology. 146(7)
To assess the impact of age, comorbidities and endocrine therapy (ET) in older breast cancer (BC) patients treated with hypofractionated radiotherapy (Hypo-RT). From June 2009 to December 2017, we enrolled in this study 735 ER-positive BC patients (s
Autor:
Francesca Di Salvo, Andrea Tittarelli, Paolo Contiero, Camilla Amati, Ron Pritzkuleit, Tina Žagar, Guy Launoy, Paolo Baili, Alessandro Borgini, David Ritchie, Alexander Katalinic, Carlo Modonesi, Elisabetta Meneghini, Martina Bertoldi, Roberto Lillini, Elodie Guillaume, Ludivine Launay
Publikováno v:
Reviews of Environmental Contamination and Toxicology ISBN: 9783030881399
Health risks at population level may be investigated with different types of environmental studies depending on access to data and funds. Options include ecological studies, case–control studies with individual interviews and human sample analysis,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c19761a0a62f8cc4df3ff05f9457d334
https://doi.org/10.1007/398_2020_58
https://doi.org/10.1007/398_2020_58
Autor:
Elisabetta Meneghini, Milena Sant, Annalisa Curcio, Paolo Baili, Serena Di Cosimo, Secondo Folli, Sara Bravaccini, Chiara Listorti, Laura Lozza, Maria De Santis, Massimiliano Gennaro
Publikováno v:
Tumori. 106(1)
Background:Ductal carcinoma in situ (DCIS) is considered a morphologic precursor of invasive cancer and is often treated with adjuvant whole-breast irradiation and endocrine therapy, as if it were an invasive cancer. Our aim was to provide further su
Autor:
Elisabetta Meneghini, F. de Braud, G. S. Di Lorenzo, Milena Sant, Giulia Galli, Maria Grazia Daidone, Giancarlo Pruneri, M Di Nicola, M. De Santis, S. Di Cosimo, Giacomo Bregni, S. Folli, E. La Rocca, Giovanni Apolone, Massimiliano Gennaro, Biagio Paolini
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 22(5)
Primary tumor characteristics, which are readily available to all clinicians, may aid in selecting the optimal adjuvant therapy for patients with breast cancer (BC). Herein, we investigated the relationship between tumor size, hormone receptor and HE
Autor:
Elisabetta, Meneghini, Roberto, Lillini, Rossella, Ballarini, Antonio, Florita, Ilaria, Cavallo, Francesco, Funaro, Simone, Bonfarnuzzo, Agata, Cifalà, Chiara, Margutti, Ilaria, Perrotta, Paolo, Bonacci, Fabrizio, Carletti, Valentina, Fracchiolla, Monica, Morelli, Antonietta, Aiello, Federica, Pizzo, Paola, Gabaldi, Giovanni, Apolone, Paolo, Baili
Publikováno v:
Recenti progressi in medicina. 110(2)
The objective is to show variations in the number of non-tenured personnel (NTP) in a public health research centre (IRCCS) between 30th June 2016 and 31st December 2017. In this time interval, the issue of NTP was at the centre of governmental discu
Autor:
Claudia Agnoli, Milena Sant, Barnett Zumoff, Paola Muti, Vittorio Krogh, Elisabetta Meneghini, Giorgio Secreto, Sabina Sieri, Sara Grioni
Publikováno v:
Breast Cancer Research and Treatment. 158:553-561
Minimizing endogenous estrogen production and activity in women at high risk for breast cancer is a prominent approach to prevention of the disease. A number of clinical trials have shown that the administration of selective-estrogen receptor modulat
Autor:
Milena Sant, Massimiliano Gennaro, Emanuele Pignoli, E. La Rocca, V. Cosentino, Laura Lozza, F. Bonfantini, Riccardo Valdagni, Elisabetta Meneghini, S. Di Cosimo, Michela Dispinzieri, M. De Santis, Alba Fiorentino
Publikováno v:
Radiotherapy and Oncology. 133:S703-S704
Autor:
Roberta De Angelis, Pamela Minicozzi, Milena Sant, Luigino Dal Maso, David H. Brewster, Gemma Osca-Gelis, Otto Visser, Marc Maynadié, Rafael Marcos-Gragera, Xavier Troussard, Dominic Agius, Paolo Roazzi, Elisabetta Meneghini, Alain Monnereau, M. Hackl, N. Zielonke, W. Oberaigner, E. Van Eycken, K. Henau, Z. Valerianova, N. Dimitrova, M. Sekerija, M. Zvolský, L. Dušek, H. Storm, G. Engholm, M. Mägi, T. Aareleid, N. Malila, K. Seppä, M. Velten, X. Troussard, V. Bouvier, G. Launoy, A.V. Guizard, J. Faivre, A.M. Bouvier, P. Arveux, M. Maynadié, A.S. Woronoff, M. Robaszkiewicz, I. Baldi, A. Monnereau, B. Tretarre, N. Bossard, A. Belot, M. Colonna, F. Molinié, S. Bara, C. Schvartz, B. Lapôtre-Ledoux, P. Grosclaude, M. Meyer, R. Stabenow, S. Luttmann, A. Eberle, H. Brenner, A. Nennecke, J. Engel, G. Schubert-Fritschle, J. Kieschke, J. Heidrich, B. Holleczek, A. Katalinic, J.G. Jónasson, L. Tryggvadóttir, H. Comber, G. Mazzoleni, A. Bulatko, C. Buzzoni, A. Giacomin, A. Sutera Sardo, P. Mancuso, S. Ferretti, E. Crocetti, A. Caldarella, G. Gatta, M. Sant, H. Amash, C. Amati, P. Baili, F. Berrino, S. Bonfarnuzzo, L. Botta, F. Di Salvo, R. Foschi, C. Margutti, E. Meneghini, P. Minicozzi, A. Trama, D. Serraino, L. Dal Maso, R. De Angelis, M. Caldora, R. Capocaccia, E. Carrani, S. Francisci, S. Mallone, D. Pierannunzio, P. Roazzi, S. Rossi, M. Santaquilani, A. Tavilla, F. Pannozzo, S. Busco, L. Bonelli, M. Vercelli, V. Gennaro, P. Ricci, M. Autelitano, G. Randi, M. Ponz De Leon, C. Marchesi, C. Cirilli, M. Fusco, M.F. Vitale, M. Usala, A. Traina, R. Staiti, F. Vitale, B. Ravazzolo, M. Michiara, R. Tumino, P. Giorgi Rossi, E. Di Felice, F. Falcini, A. Iannelli, O. Sechi, R. Cesaraccio, S. Piffer, A. Madeddu, F. Tisano, S. Maspero, A.C. Fanetti, R. Zanetti, S. Rosso, P. Candela, T. Scuderi, F. Stracci, F. Bianconi, G. Tagliabue, P. Contiero, A.P. Dei Tos, S. Guzzinati, S. Pildava, G. Smailyte, N. Calleja, D. Agius, T.B. Johannesen, J. Rachtan, S. Gózdz, R. Mezyk, J. Blaszczyk, M. Bebenek, M. Bielska-Lasota, G. Forjaz de Lacerda, M.J. Bento, C. Castro, A. Miranda, A. Mayer-da-Silva, F. Nicula, D. Coza, C. Safaei Diba, M. Primic-Zakelj, E. Almar, C. Ramírez, M. Errezola, J. Bidaurrazaga, A. Torrella-Ramos, J.M. Díaz García, R. Jimenez-Chillaron, R. Marcos-Gragera, A. Izquierdo Font, M.J. Sanchez, D.Y.L. Chang, C. Navarro, M.D. Chirlaque, C. Moreno-Iribas, E. Ardanaz, J. Galceran, M. Carulla, M. Lambe, S. Khan, M. Mousavi, C. Bouchardy, M. Usel, S.M. Ess, H. Frick, M. Lorez, C. Herrmann, A. Bordoni, A. Spitale, I. Konzelmann, O. Visser, V. Lemmens, M. Coleman, C. Allemani, B. Rachet, J. Verne, N. Easey, G. Lawrence, T. Moran, J. Rashbass, M. Roche, J. Wilkinson, A. Gavin, C. Donnelly, D.H. Brewster, D.W. Huws, C. White, R. Otter
Publikováno v:
European Journal of Cancer. 51:2254-2268
BACKGROUND: Significant advances in the management of patients with lymphoid and myeloid malignancies entered clinical practice in the early 2000's. The EUROCARE-5 study database provides an opportunity to assess the impact of these changes at the po